Key Market Indicators
**Lithuanian Vaccination Coverage Remains Steady at 92% for Children Aged 1 Year** Lithuania's vaccination coverage for children aged one year is projected to remain stable at 92% by 2028, unchanged from 2023. This consistency continues a trend that has been observed since 1997, reflecting the country's strong public health infrastructure and commitment to immunization programs. **Vaccine Exports Expected to Grow** In terms of vaccine exports, Lithuania is set to see a modest increase. By 2028, the country's vaccine exports are projected to reach $5.8 million, up from $5.2 million in 2023. This represents an annual compound growth rate of 1.7% since 1999, when the growth rate was 0.7% year on year. In the global rankings for 2023, Lithuania stood at number 35, with New Zealand slightly ahead at $5.2 million. Belgium, the United Kingdom, and France occupied the top three positions respectively. **Rising Vaccine Imports** Lithuania's vaccine imports are also on the rise. They are expected to grow to $24.3 million by 2028, up from $21.2 million in 2023. This growth represents an average annual increase of 2% since 1999, during which time the demand has been climbing at a rate of 2.5% year on year. These figures underscore Lithuania's growing role in the global vaccine market, both as an exporter and importer, and highlight the country's commitment to maintaining high vaccination rates among its young population.
